This invention relates to the use of the IL-2 common gamma chain (c.gamma.c) and related molecules for the modulation of signal activities controlled by NIK, and some new such molecules.

 
Web www.patentalert.com

< Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

> Pyrazine based inhibitors of glycogen synthase kinase 3
~ 00457